Sleep benefit in Parkinson's disease

Journal of Neurology Neurosurgery and Psychiatry

Volumn 67, Issue 3, 1999, Pages 384-385

  Bateman, D E ^a   Levett, K ^b   Marsden, C D ^c  

^a ROYAL UNITED HOSPITAL   (United Kingdom)

^b Bath Branch Parkinson's Disease Society   (United Kingdom)

^c NATIONAL HOSPITAL FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BROMOCRIPTINE; LEVODOPA; SELEGILINE;

ARTICLE; DAILY LIFE ACTIVITY; HUMAN; MAJOR CLINICAL STUDY; PARKINSON DISEASE; PRIORITY JOURNAL; RATING SCALE; SLEEP;

EID: 0032799828     PISSN: 00223050     EISSN: None     Source Type: Journal    
DOI: 10.1136/jnnp.67.3.384     Document Type: Article

References (7)

1. Marsden CD. On-off phenomena in Parkinson's disease. In: Rinne UK, Klinger M, Stamm G, eds. Parkinson's disease: current progress, problems and management. Amsterdam: Elsevier North Holland, 1980:241-54.
2. Comella CL, Bohmer J, Stebbins GT. Sleep benefit in Parkinson's disease [abstract]. Neurology 1995;45(suppl 4):A286.
3. Currie LJ, Bennett Jr JP, Harrison MB, et al. Clinical correlates of sleep benefit in Parkinson's disease. Neurology 1997;48:1115-17.
4. Fahn S, Elton RL. Members of the UPDRS Committee. Unified Parkinson's disease rating scale. In: Fahn S, Marsden CD, Goldstein M, eds. Recent developments in Parkinson's disease. 2nd ed. New York: Macmillan, 1987;153-63, appendices I, II.
5. Brown RG, MacCarthy B, Jahanshahi M, et al. Accuracy of self-reported disability in patients with parkinsonism. Arch Neurol 1989;46:955-9.
6. Hoehn MM, Yahr MD. Parkinsonism: onset, progression and mortality. Neurology 1967;17:427-12.
7. Quinn N, Critchley P, Marsden CD. Young-onset Parkinson's disease, Mov Disord 1987;2:73-91.